Literature DB >> 15047849

The leader protein of Theiler's virus interferes with nucleocytoplasmic trafficking of cellular proteins.

Sophie Delhaye1, Vincent van Pesch, Thomas Michiels.   

Abstract

The leader protein of Theiler's virus was previously shown to block the production of alpha/beta interferon by infected cells. Here, we observed that expression of the leader protein in infected cells triggered subcellular redistribution of a nucleus-target green fluorescent protein. It enhanced redistribution of the nuclear polypyrimidine tract-binding protein but had no influence on the localization of the nuclear splicing factor SC-35. The leader protein also interfered with trafficking of the cytoplasmic interferon regulatory factor 3, a factor critical for transcriptional activation of alpha/beta interferon genes.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15047849      PMCID: PMC374251          DOI: 10.1128/jvi.78.8.4357-4362.2004

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  26 in total

1.  Inhibition of nuclear import and alteration of nuclear pore complex composition by rhinovirus.

Authors:  Kurt E Gustin; Peter Sarnow
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

2.  The mengovirus leader protein suppresses alpha/beta interferon production by inhibition of the iron/ferritin-mediated activation of NF-kappa B.

Authors:  Jan Zoll; Willem J G Melchers; Jochem M D Galama; Frank J M van Kuppeveld
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

3.  Tight control of gene expression in mammalian cells by tetracycline-responsive promoters.

Authors:  M Gossen; H Bujard
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-15       Impact factor: 11.205

4.  Theiler's virus infection in mice: an unusual biphasic disease process leading to demyelination.

Authors:  H L Lipton
Journal:  Infect Immun       Date:  1975-05       Impact factor: 3.441

5.  Early alteration of nucleocytoplasmic traffic induced by some RNA viruses.

Authors:  G A Belov; A G Evstafieva; Y P Rubtsov; O V Mikitas; A B Vartapetian; V I Agol
Journal:  Virology       Date:  2000-09-30       Impact factor: 3.616

Review 6.  Overlapping and distinct mechanisms regulating IRF-3 and IRF-7 function.

Authors:  Marc J Servant; Benjamin Tenoever; Rongtuan Lin
Journal:  J Interferon Cytokine Res       Date:  2002-01       Impact factor: 2.607

7.  Regulated nuclear-cytoplasmic localization of interferon regulatory factor 3, a subunit of double-stranded RNA-activated factor 1.

Authors:  K P Kumar; K M McBride; B K Weaver; C Dingwall; N C Reich
Journal:  Mol Cell Biol       Date:  2000-06       Impact factor: 4.272

8.  Mengovirus leader is involved in the inhibition of host cell protein synthesis.

Authors:  J Zoll; J M Galama; F J van Kuppeveld; W J Melchers
Journal:  J Virol       Date:  1996-08       Impact factor: 5.103

9.  The leader protein of Theiler's virus inhibits immediate-early alpha/beta interferon production.

Authors:  V van Pesch; O van Eyll; T Michiels
Journal:  J Virol       Date:  2001-09       Impact factor: 5.103

10.  La autoantigen enhances and corrects aberrant translation of poliovirus RNA in reticulocyte lysate.

Authors:  K Meerovitch; Y V Svitkin; H S Lee; F Lejbkowicz; D J Kenan; E K Chan; V I Agol; J D Keene; N Sonenberg
Journal:  J Virol       Date:  1993-07       Impact factor: 5.103

View more
  62 in total

1.  Different strains of Theiler's murine encephalomyelitis virus antagonize different sites in the type I interferon pathway.

Authors:  Spyridon Stavrou; Zongdi Feng; Stanley M Lemon; Raymond P Roos
Journal:  J Virol       Date:  2010-07-07       Impact factor: 5.103

2.  Selective Removal of FG Repeat Domains from the Nuclear Pore Complex by Enterovirus 2A(pro).

Authors:  Nogi Park; Nicholas J Schweers; Kurt E Gustin
Journal:  J Virol       Date:  2015-08-26       Impact factor: 5.103

3.  A picornavirus protein interacts with Ran-GTPase and disrupts nucleocytoplasmic transport.

Authors:  Frederick W Porter; Yury A Bochkov; Alison J Albee; Christiane Wiese; Ann C Palmenberg
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-03       Impact factor: 11.205

4.  The leader protein of cardioviruses inhibits stress granule assembly.

Authors:  Fabian Borghese; Thomas Michiels
Journal:  J Virol       Date:  2011-07-13       Impact factor: 5.103

5.  The L-coding region of the DA strain of Theiler's murine encephalomyelitis virus causes dysfunction and death of myelin-synthesizing cells.

Authors:  G D Ghadge; R Wollmann; G Baida; M Traka; R P Roos
Journal:  J Virol       Date:  2011-07-13       Impact factor: 5.103

6.  Persistent infection of RAW264.7 macrophages with the DA strain of Theiler's murine encephalomyelitis virus: An in vitro model to study viral persistence.

Authors:  Stephane Steurbaut; Bart Rombaut; Raf Vrijsen
Journal:  J Neurovirol       Date:  2006-04       Impact factor: 2.643

7.  Leader-induced phosphorylation of nucleoporins correlates with nuclear trafficking inhibition by cardioviruses.

Authors:  Frederick W Porter; Ann C Palmenberg
Journal:  J Virol       Date:  2008-12-10       Impact factor: 5.103

8.  Phylogenetic analysis of the species Theilovirus: emerging murine and human pathogens.

Authors:  Zhiguo Liang; A S Manoj Kumar; Morris S Jones; Nick J Knowles; Howard L Lipton
Journal:  J Virol       Date:  2008-09-24       Impact factor: 5.103

9.  Mengovirus-induced rearrangement of the nuclear pore complex: hijacking cellular phosphorylation machinery.

Authors:  Maryana V Bardina; Peter V Lidsky; Eugene V Sheval; Ksenia V Fominykh; Frank J M van Kuppeveld; Vladimir Y Polyakov; Vadim I Agol
Journal:  J Virol       Date:  2009-01-14       Impact factor: 5.103

10.  Interactions between viral and prokaryotic pathogens in a mixed infection with cardiovirus and mycoplasma.

Authors:  Peter V Lidsky; Lyudmila I Romanova; Marina S Kolesnikova; Maryana V Bardina; Elena V Khitrina; Stanleyson V Hato; Frank J M van Kuppeveld; Vadim I Agol
Journal:  J Virol       Date:  2009-07-15       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.